Skip to content

In This Article

  • At the ACC.18 Scientific Session and Expo, physicians and researchers from Mass General's Corrigan Minehan Heart Center will present their world-leading research and innovative approaches
  • Sessions highlight approaches for the prevention and treatment of cardiac disease and late-breaking science
  • This article highlights eight can't miss sessions and presentations

The American College of Cardiology is hosting their 2018 Scientific Session and Expo (ACC.18) in Orlando, Florida from March 10-12. Physicians and researchers from the Massachusetts General Hospital Corrigan Minehan Heart Center will present their world-leading research, late-breaking science, and innovative approaches for preventing and treating cardiac disease.

From biomarkers to blood pressure, the topics discussed and presented at ACC.18 foster a dialogue that contributes to the transformation of cardiovascular care in the practice setting, and the improvement of heart health for patients.

Here’s a list of some Mass General sessions and presentations that can’t be missed:

  1. Biomarkers in Heart Failure: Where Are We Now and What’s the Future?
    The study of biomarkers continues to evolve, and these clinical indicators have the potential to play a major role in the recognition of disease and precision medicine. Hanna Gaggin, MD, MPH, a researcher investigating biomarkers, will be co-chairing this session focused on the application of biomarkers in heart failure, beginning with stage A through stage C and D, with a vision of where the field is moving. James Januzzi, MD, a cardiac biomarker expert, will address unresolved questions pertaining to biomarkers.
  2. The Future of Health Technology and Innovation @ the Future Hub Theater (Part II)
    This session, moderated by Maulik Majmudar, MD, associate director of Mass General’s Healthcare Transformation Lab (HTL), will present and discuss the latest innovations in digital health, medical devices and educational technology. Ami Bhatt, MD, director of the Mass General Adult Congenital Heart Disease Program and a clinical affiliate with the HTL, will present her experience with virtual visits, and make a case for their use in clinical practice.
  3. The Aorta in ACHD: Too Small or Too Big, or Just Right?
    This session, co-chaired by esteemed cardiac surgeon Duke Cameron, MD, addresses aortic involvement in congenital heart disease, including recommendations for active surveillance and timing of intervention. Dr. Cameron will specifically discuss thresholds for interventions in aortic aneurysm.
  4. Fellows-in-Training (FIT) Forum: Acing the Transition: What FITs Need to Know to Launch a Healthy, Successful Career
    Fellows-in-training (FIT) are expected to achieve knowledge and experience in several clinical and non-clinical competencies as they transition into practice. This session will address interviewing and negotiation, and discuss strategies for effective communication and networking. Topics include:
    • Key elements of the job search strategy
    • The “elevator speech”
    • Selecting the right position
    • How to successfully present yourself as a new hire
    • Strategies for starting a career with a healthy work-life balance
    Doreen DeFaria Yeh, MD, associate director of the Mass General Adult Congenital Heart Disease Program, will present on pragmatic approaches to selecting the right practice after fellowship.
  5. Multidisciplinary Response Teams for High-Risk PE and DVT: Respond Like a Pro
    Integrative teams are crucial and becoming increasingly more common when it comes to responding to high-risk cardiovascular events. This entire session takes a case based approach to difficult PE and DVT cases. David Dudzinski, MD, co-director of the Cardiac Intensive Care Unit at Mass General, will present his experience with a 37-year-old woman with ulcerative colitis, saddle PE, hypoxemia and hypotension.
  6. STEMI Hot Debates: Trials and Tribulations
    When it comes to treating one of the most serious myocardial infarctions, there is no consensus on the optimal course of treatment. Farouc Jaffer, MD, director of Coronary Intervention at Mass General, takes the opposition to culprit-only revascularization and presents on why he believes complete revascularization is the way to go.
  7. Pitfalls in Assessing Valvular Heart Disease
    This session focuses on the future directions in guidelines and importance of disease-specific protocols in acquisition and reporting of valvular heart disease. Judy Hung, MD, associate director of Echocardiography at Mass General, tackles one of the more complex areas of the disorder in her presentation titled “Tinker, Tailor, Soldier, Valve: Pitfalls in Acquisition and Interpretation of Mitral Valve Disease.
  8. Development of a Multiple Biomarker Panel For the Identification of Severe Aortic Stenosis: Results From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study
    Valvular aortic stenosis (AS) is challenging to correctly diagnose. Sammy Elmariah, MD, director, Interventional Structural Heart Disease, presents his research on the development of a biomarker panel to identify patients with severe AS, eliminating the need for a stress echocardiogram.

What session are you most looking forward to? Comment below.

Visit the ACC.18 Website

Learn about the Corrigan Minehan Heart Center


At this year’s AHA Scientific Sessions, Maulik Majmudar, MD, cardiologist and associate director of the Healthcare Transformation Lab at Massachusetts General Hospital, chairs the day-long Health Tech Summit. Dr. Majmudar answers some questions about the importance of health technology and the role it plays at conferences like the Scientific Sessions.


Health care professionals at this year’s American Heart Association’s Scientific Sessions discussed late-breaking research, innovative treatment approaches and brand new guidelines. The conversations carried over from the podium and conference halls onto Twitter.